A 5`-tRNA Derived Fragment NamedtiRNA-Val-CAC-001 Works as a Suppressor in Gastric Cancer

Abstract

Background Gastric cancer (GC) is a common type of gastrointestinal tumor in the world. Transfer RNA (tRNA) derived fragments (tsRNAs) implicate various cancers, but their roles in GC remain unclear. Our study aimed to investigate the potential biological functions and molecular mechanisms of tsRNAs in GC. Methods Differentially expressed tsRNAs were identified using high-throughput sequencing. The expression levels of tsRNAs were validated in 62 paired GC tissues and adjacent normal tissues using RT-qPCR. In vitro functional assays were used to evaluate the influences of tsRNAs on GC cells. The potential mechanisms underlying tsRNAs were explored using bioinformatics analysis,RT-qPCR, RNA immunoprecipitation assays and Western blot. Results We found that tiRNA-Val-CAC-001 was downregulated in GC tissues and cells, and demonstrated that tiRNA-Val-CAC-001 was a tsRNA sheared from mature tRNA-Val and mainly localized in the cytoplasm. tiRNA-Val-CAC-001 overexpression inhibited metastasis and proliferation but promoted apoptosis of GC cells; nevertheless, tiRNA-Val-CAC-001 knockdown increased metastasis and proliferation and reduced apoptosis ( P <0.05). GO and KEGG analyses indicated tiRNA-Val-CAC-001 may exert its effects via Wnt/β-catenin signaling pathway by targeting LRP6. Following experiments showed that tiRNA-Val-CAC-001 could downregulated the protein levels of LRP6 and β-catenin, but up-regulated p-β-catenin, which confirmed the findings in bioinformatics analysis. Conclusion In conclusion, tiRNA-Val-CAC-001 works as a cancer suppressor in GC by targeting LRP6 via Wnt/β-catenin signaling pathway. tiRNA-Val-CAC-001 may serve as a therapy target and a biomarker of GC in the future. Key Points tiRNA-Val-CAC-001 is downregulated in gastric cancer tissues and cell lines, tiRNA-Val-CAC-001 has potential to become a novel diagnostic biomarker in gastric cancer, and tiRNA-Val-CAC-001 regulates gastric cancer cells by targeting LRP6.

A novel tRNA-derived fragment tRF-17-18VBY9M works as a potential diagnostic biomarker for gastric cancer

“…Numerous studies have shown that tsRNAs are related to metastasis, proliferation, cell cycle, and apoptosis (Li et al 2018 ; Sun et al 2018 ; Telonis et al 2019 ). For example, Zheng et al found that high-expressed tiRNA-Val-CAC-001 inhibited the metastasis and proliferation of gastric cancer cells, but promoted apoptosis in GC, and tiRNA-Val-CAC-001 may act as a tumor suppressor and therapeutic target (Zheng et al 2022 ). Although research on tsRNA is still in its infancy, with the advancement of technology and thorough investigation, humans will have a more extensive and in-depth grasp of tsRNA and its biological characteristics and functions in associated diseases.…”

Pancreatic stellate cell‐derived exosomal tRF‐19‐PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through AXIN2

“…Through their interaction with proteins or mRNA, inhibition of translation and regulation of gene expression, tRFs play biological roles 23 . It has also been observed that dysregulation of tDRs is associated with several cancers, including PC 24–26 . tRFs are part of tDRs and formed by the processing of tRNA by nucleases such as DICER and angiopoietin under certain conditions 27,28 .…”

Gallocatechin Gallate Inhibits the Replication of Pseudorabies Virus via Suppressing the Entry and Release Stages in Its Replication Cycle

“…Using the CCK-8 reagent, the viability of PK15 cells after gallocatechin gallate treatment was determined as previously reported [ 21 ]. PK15 cells were preseeded in 96-well plates at 2 × 10 4 cells/well.…”